By Drug Target Review2025-10-06T08:30:29
Researchers have discovered a surface protein that helps acute myeloid leukaemia cells evade the immune system, offering potential insights to aid the development of new treatments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-02-06T08:57:06
Sponsored by bit.bio
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-11-20T13:43:43
Sponsored by Merck
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
Site powered by Webvision Cloud